RxDoctor Payments Data

Alba Rivera Burgos, APRN

Family · Tampa, FLNPI 1659069979

Payments from drug & device makers

$2,988in general payments, 2019–2025

Across 44 payments — averaging $67.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Medtronic$942
  • Sumitomo Pharma America, Inc.$81
  • Hologic Sales And Service, LLC$63
  • Astellas Pharma US Inc$42
  • Millicent US Inc$41
  • plus $95 from 4 others

What the payments were for

  • Travel & lodging$2,04468%
  • Food & beverage$91831%
  • Education$271%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,988 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$55,245
Medicare patients
233
Services billed
889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron209$176,957
MyrbetriqMirabegron183$120,533
Estradiol338$20,278
PremarinEstrogens, Conjugated40$17,619
EstringEstradiol19$10,579
Methenamine Hippurate75$9,347
Trimethoprim25$1,483
NitrofurantoinNitrofurantoin Macrocrystal21$1,034
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst87$772
Metronidazole19$601
Cefdinir53$548
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet24$310
Ibuprofen45$292
Clobetasol Propionate15$274
Oxycodone Hcl47$139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$81$176,957209 claims
Astellas Pharma US IncMyrbetriq$42$120,533183 claims
PfizerPremarin, Estring$19$28,19959 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.

Other family in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →